(2020) Efficacy of β-D-Mannuronic Acid M2000 on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC. Current drug discovery technologies. pp. 225-232.

(2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology. ISSN 1568-5608

(2018) Efficacy of β-D-mannuronic acid [M2000] on pro-apoptotic process and inflammatory related molecules NFҡB, IL-8 and Cd49d using healthy donor PBMC. Current drug discovery technologies. ISSN 1875-6220

(2018) Effect of β-D-mannuronic acid (M2000) on oxidative stress enzymes' gene using healthy donor peripheral blood mononuclear cells for evaluating the anti-aging property. Current drug discovery technologies. ISSN 1875-6220

(2018) Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial. International immunopharmacology. pp. 112-117. ISSN 1878-1705